Immunophotonics, Inc.

Immunophotonics, Inc.

Pharmaceutical Manufacturing Ch 19 employees
Employees
19
Contacts
3
Emails
3
Phones
2

Immunophotonics, Inc. Overview

Headquarters
Ch
Phone Number
Available in AeroLeads
Industry
Pharmaceutical Manufacturing
Employees
19
Founded
2012
Funding
1.5M
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Immunophotonics, Inc.

Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their surveillance of tumor tissue and can generate long-term protective immunity.

Immunophotonics, Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Immunophotonics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Jacqueline Hess Experienced Non-executive Director
View
Bobby W Sandage, Jr., Phd Managing Director at the Paula
Email Phone
Troy Jiao CEO
Email
Robert Arch Pharma and Biotech Executive
Email Phone

Employees by Management Level

Director 3 profiles
Executive 2 profiles
Individual contributor 2 profiles
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 1
Healthcare 1 1 0

Compare Similar Companies to Immunophotonics, Inc.